Search for a full or partial Catalog Number, CAS Number or description
Product Catalog
CAS Number: 10043-35-3
05-0205
Boron › Boric acid (99.9995%-B) PURATREM| CAS Number: | 10043-35-3 |
| MDL Number: | MFCD00011337 |
| Molecular Formula: | BH3O3 |
| Molecular Weight: | 61.83 |
| Chemical Formula: | H3BO3 |
| Color and Form: | white xtl. |
| Note: |
Physical Characteristics: melting point 171°C, density 1.435
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Boric acid (99.9995%-B) PURATREM |
| Product Number: | 05-0205 |
| CAS Registry Number: | 10043-35-3 |
| Formula: | H3BO3 |
| EINECS Number: | 233-139-2 |
| Chemical Family: | inorganic acid |
| Synonym: | Boracic acid, Orthoboric acid |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 10043-35-3 | 100 | no data | no data |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to eyes, skin and respiratory tract. Harmful by inhalation, in contact with skin and if swallowed. Possible risk of harm to the unborn child, impaired fertility and irreversible effects. |
| Primary Routes of Exposure: | Ingestion, inhalation, skin and eyes. |
| Eye Contact: | The dust causes slight to mild irritation of the eyes. Symptoms include redness, and pain. |
| Skin Contact: | The dust causes irritation and dryness of the skin and skin rash. |
| Inhalation: | Harmful by inhalation. Irritating to the nose, mucous membranes and respiratory tract. Symptoms include coughing, wheezing and sore throat. |
| Ingestion: | Harmful if swallowed. High doses may cause boron poisoning, convulsions, cyanosis, coma and death. |
| Acute Health Effects: | Irritating to eyes skin and respiratory tract. High doses may cause convulsions, cyanosis, coma and death. Possible risk of harm to the unborn child. |
| Chronic Health Effects: | Repeated ingestion of boron compounds may cause dryness of mucous membranes, anorexia, vomiting, mild diarrhea, skin rash, and low blood cell count. Kidney damage may occur. Possible risk of impaired fertility and irreversible effects. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable. |
| Special Fire Fighting Procedures: | Fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may form toxic boron oxide dust. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a cool dry place in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | white xtl. |
| Molecular Weight: | 61.83 |
| Melting Point: | 171°C |
| Boiling Point: | no data |
| Vapor Pressure: | no data |
| Specific Gravity: | 1.435 |
| Odor: | none |
| Solubility in Water: | 6.35g/100cc (30°C) |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | None |
| Decomposition Products: | Boron oxide |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Admin. onto the skin (Human); Standard Draize test: 15 mg/3D (Intermittent). Oral (Human-man); LDLo: 429 mg/kg. Oral (Human-child); TDLo: 500 mg/kg. Oral (Human-woman); LDLo: 200 mg/kg. Oral (Human-infant); TDLo: 800 mg/kg/4W-I. Oral (Human-infant); LDLo: 934 mg/kg. Admin. onto the skin (Human-infant); LDLo: 1200 mg/kg. Admin. onto the skin (Human-child); LDLo: 4 gm/kg/4D. Administration onto the skin (Human-man);LDLo: 2430 mg/kg. Admin. onto the skin (Human-child); 1500 mg/kg. Subcutaneous (Human-infant); LDLo: 1100 mg/kg. Unreported (Human-man); LDLo: 147 mg/kg. Oral (rat); LD50: 2660 mg/kg. Inhalation (rat); LDLo: 28 mg/m3/4H. |
| Carcinogenic Effects: | Insufficient data |
| Mutagenic Effects: | Possible mutagen |
| Tetratogenic Effects: | Possible reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to federal, state, and local regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Title compound not listed. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 7/17/2002 |
| Revision Date: | 8/22/2011 |
